BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3740651)

  • 1. Orally administered nifedipine in chronic stable asthma. Comparison with an orally administered sympathomimetic.
    Schwartzstein RS; Fanta CH
    Am Rev Respir Dis; 1986 Aug; 134(2):262-5. PubMed ID: 3740651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nifedipine in chronic bronchial asthma: a randomized double-blind crossover trial against placebo.
    Ozenne G; Moore ND; Leprevost A; Tardif C; Boismare F; Pasquis P; Lemercier JP
    Eur J Respir Dis; 1985 Oct; 67(4):238-43. PubMed ID: 3908132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nifedipine on allergen-induced bronchoconstriction.
    Crimi N; Palermo F; Gibellino F; Vancheri C; Palermo B; Oliveri R; Mistretta A
    Allergol Immunopathol (Madr); 1986; 14(4):263-8. PubMed ID: 3776776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibitory effect of nebulized albuterol on the early and late asthmatic reactions and increase in airway responsiveness provoked by inhaled allergen in asthma.
    Twentyman OP; Finnerty JP; Holgate ST
    Am Rev Respir Dis; 1991 Oct; 144(4):782-7. PubMed ID: 1928949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single-dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects.
    Gongora HC; Wisniewski AF; Tattersfield AE
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):626-9. PubMed ID: 1679981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma.
    Gaddy JN; Margolskee DJ; Bush RK; Williams VC; Busse WW
    Am Rev Respir Dis; 1992 Aug; 146(2):358-63. PubMed ID: 1489125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy with nifedipine in asthma: a randomized double-blind crossover trial.
    Lidji M; Molho M; Chagnac A; Katz I; Benzaray S
    Isr J Med Sci; 1988 Jan; 24(1):1-4. PubMed ID: 3279010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchodilatation and attenuation of exercise-induced bronchospasm by PY 108-068, a new calcium antagonist.
    Ben-Dov I; Sue DY; Hansen JE; Wasserman K
    Am Rev Respir Dis; 1986 Jan; 133(1):116-9. PubMed ID: 3942368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does nifedipine affect the diurnal variation of asthma in children?
    Sly PD; Olinsky A; Landau LI
    Pediatr Pulmonol; 1986; 2(4):206-10. PubMed ID: 3532009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma.
    Rabe KF; Jörres R; Nowak D; Behr N; Magnussen H
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1436-41. PubMed ID: 8503554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction.
    Inman MD; O'Byrne PM
    Am J Respir Crit Care Med; 1996 Jan; 153(1):65-9. PubMed ID: 8542164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nifedipine on antigen-induced bronchoconstriction.
    Henderson AF; Heaton RW; Dunlop LS; Costello JF
    Am Rev Respir Dis; 1983 May; 127(5):549-53. PubMed ID: 6303164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nifedipine on salbutamol-induced bronchodilation in partially reversible airway obstruction.
    Rolla G; Arossa W; Bucca C; Bugiani M
    Int J Clin Pharmacol Res; 1986; 6(5):409-13. PubMed ID: 3781703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of nifedipine in subjects with bronchial asthma and COPD.
    Nair N; Townley RG; Bewtra A; Nair CK
    Chest; 1984 Oct; 86(4):515-8. PubMed ID: 6478889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sodium cromoglycate and nifedipine on adenosine-induced bronchoconstriction.
    Crimi N; Palermo F; Vancheri C; Oliveri R; Distefano SM; Polosa R; Mistretta A
    Respiration; 1988; 53(2):74-80. PubMed ID: 2455927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formoterol, a new inhaled beta-2 adrenergic agonist, has a longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction.
    Malo JL; Cartier A; Trudeau C; Ghezzo H; Gontovnick L
    Am Rev Respir Dis; 1990 Nov; 142(5):1147-52. PubMed ID: 1978619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The influence of salmeterol and salbutamol on bronchial constriction in patients with bronchial asthma].
    Tymińska K; Grzelewska-Rzymowska I; Kroczyńska-Bednarek J; Kwiatkowska S
    Pneumonol Alergol Pol; 1998; 66(11-12):524-9. PubMed ID: 10391959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nifedipine in asthma. Dose-related effect on resting bronchial tone.
    Molho M; Gruzman C; Katz I; Lidgi M; Chaniac A
    Chest; 1987 May; 91(5):667-70. PubMed ID: 3552464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.